IFLO I-Flow Corporation featured news, full reports, and detailed charts
I-Flow Corporation (IFLO) Wrap Up:
I-Flow Corporation (the “Company” or “I-Flow”) is improving surgical outcomes by designing, developing and marketing technically-advanced, low-cost drug delivery systems and innovative surgical products for post-surgical pain relief and surgical site care. The Company’s products are used in hospitals, home and other settings, including free-standing surgery centers and physicians’ offices. Since it began in 1985, I-Flow has established a reputation in the medical and health care industry as an innovator in drug delivery technology. Through product advancements and strategic acquisitions, the Company has emerged as a leader in post-surgical pain relief, offering highly effective therapies that deliver superior outcomes for physicians and their patients. I-Flow’s ON-Q® brand products provides reliable and simple post-surgical pain relief that eliminates many of the side effects customarily associated with narcotics. ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2008%2f03%2f17%2f0000892569-08-000331.html#FIS_BUSINESS"I-Flow Corp. (IFLO:NASDAQ)
Snapshot of I-Flow Corp. (IFLO)
|
OPEN
$12.64
|
PREVIOUS CLOSE
$12.64
|
|
|
DAY HIGH
$12.65
|
DAY LOW
$12.64
|
|
|
52 WEEK HIGH
10/2/09 - $12.95
|
52 WEEK LOW
03/10/09 - $2.01
|
|
|
MARKET CAP
309.2M
|
AVERAGE VOLUME 3 mo
352.8K
|
|
|
DILUTED EPS TTM
$-0.25
|
SHARES OUTSTANDING
24.5M
|
|
|
IFLO Does Not Pay Dividends
|
P/E TTM
NM
|
|
| K = Thousands M = Millions B = Billions | ||
IFLO Top Compensated Officers
Executives, Board Directors
Key developments for I-Flow Corp. (IFLO)
I-Flow Corp. reported consolidated unaudited earnings results for third quarter and nine months ended September 30, 2009. For the quarter, the company reported net income of $670,000 or $0.03 per diluted share on net revenues of $36,747,000 compared to net loss of $14,127,000 or $0.57 loss per diluted share on net revenues of $32,242,000 for the same period a year ago. Income before income taxes was $1,909,000 compared to loss before income taxes of $15,364,000 for the same period a year ago. For nine months period the company reported net loss of $1,790,000 or $0.07 loss per diluted share on net revenues of $104,756,000 compared to net loss of $26,089,000 or $1.05 loss per diluted share on net revenues of $95,973,000 for the same period a year ago. Income before income taxes was $987,000 compared to loss before income taxes of $28,194,000 for the same period a year ago.
Stull, Stull & Brody has commenced an investigation on behalf of shareholders of I-Flow Corp. for possible breaches of fiduciary duty and other violations of state law in connection with an agreement by I-Flow's Board of Directors to sell all of the Company's outstanding shares of common stock at a price of $12.65 per share in cash to Kimberly-Clark Corporation. The investigation concerns the price to be paid by Kimberly-Clark to I-Flow shareholders and the process by which I-Flow's Board of Directors is addressing the transaction. As recently as October 2, 2009, I-Flow's common stock traded at $12.95 per share.
Law office of Brodsky & Smith, LLC announced that it is investigating potential claims against the Board of Directors of I-Flow Corporation. relating to the proposed acquisition Kimberly-Clark Corporation. Kimberly-Clark has agreed to acquire I-Flow in an all-cash deal valued at approximately $276 million. Under the proposed agreement, I-Flow shareholders will receive $12.65 for every share of I-Flow common stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law related to the I-Flow board's approval of the proposed merger. The transaction appears to be unfair, in part, given that I-Flow stock was trading at $12.45 a share as recently as October 5, 2009 and $12.14 on September 28, 2009.
IFLO Competitors
| Company | Last | Change |
| Akorn Inc | $1.61 USD | +0.01 |
| Durect Corp | $2.09 USD | -0.02 |
| Inovio Biomedical Corp | $1.53 USD | +0.33 |
| NeurogesX Inc | $8.45 USD | +0.07 |
| QLT Inc | C$3.91 CAD | -0.04 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | IFLO | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 2.2x |
|
| Price/Book | 2.6x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 1.8x |
|
|
IFLO |
||
IFLO transactions
| Type Date |
Target |
|
Merger/Acquisition
October 8, 2009 |
-- |
